Multimodality imaging in hypertrophic cardiomyopathy is crucial to confirm diagnosis, assess left ventricular outflow tract obstruction, and stratify the risk of sudden cardiac death.
Does multimodality imaging improve sudden cardiac death risk stratification in patients with hypertrophic cardiomyopathy?
Multimodality imaging plays a crucial role in the comprehensive assessment and sudden cardiac death risk stratification of patients with hypertrophic cardiomyopathy.
Absolute Event Rate: 0% vs 0%
In hypertrophic cardiomyopathy, multimodality imaging is crucial to confirm diagnosis, assess for presence and mechanism of left ventricular outflow tract obstruction, and risk stratification for sudden cardiac death. This review will focus on the application of imaging to assess established and emerging factors to be considered in sudden cardiac death risk stratification.
Tower‐Rader et al. (Sat,) reported a other. Multimodality imaging in hypertrophic cardiomyopathy is crucial to confirm diagnosis, assess left ventricular outflow tract obstruction, and stratify the risk of sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: